Prostate cancer and microfluids
- PMID: 33934962
- DOI: 10.1016/j.urolonc.2021.03.010
Prostate cancer and microfluids
Abstract
Microfluidic systems aim to detect sample matter quickly with high sensitivity and resolution, on a small scale. With its increased use in medicine, the field is showing significant promise in prostate cancer diagnosis and management due, in part, to its ability to offer point-of-care testing. This review highlights some of the research that has been undertaken in respect of prostate cancer and microfluidics. Firstly, this review considers the diagnosis of prostate cancer through use of microfluidic systems and analyses the detection of prostate specific antigen, proteins, and circulating tumor cells to highlight the scope of current advancements. Secondly, this review analyses progressions in the understanding of prostate cancer physiology and considers techniques used to aid treatment of prostate cancer, such as the creation of a micro-environment. Finally, this review highlights potential future roles of microfluidics in assisting prostate cancer, such as in exosomal analysis. In conclusion, this review shows the vast scope and application of microfluidic systems and how these systems will ensure advancements to future prostate cancer management.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
Conflict of interests The authors declare no conflicts of interests
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
